134 related articles for article (PubMed ID: 4612561)
1. [Natural substances with carcinostatic properties].
Strauch R; Hiller K
Pharmazie; 1974; 29(10-11):656-70. PubMed ID: 4612561
[No Abstract] [Full Text] [Related]
2. Screening study on Taiwan plants for antitumor activities.
King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
[No Abstract] [Full Text] [Related]
3. [Cancerostatic ingredients of higher plants].
Becker H
Mitt Dtsch Pharm Ges Pharm Ges DDR; 1971 Dec; 41(12):309-21. PubMed ID: 4945822
[No Abstract] [Full Text] [Related]
4. Plant products in cancer chemotherapy.
Carter SK; Livingston RB
Cancer Treat Rep; 1976 Aug; 60(8):1141-56. PubMed ID: 791484
[No Abstract] [Full Text] [Related]
5. [Isolation of a polymer from Chamaenerium angustifolium and study of its antineoplastic action].
Pukhal'skaia ECh; Petrova MF; Kibal'chich PN; Alieva TA; Denisova SI
Antibiotiki; 1970 Sep; 15(9):782-5. PubMed ID: 5536919
[No Abstract] [Full Text] [Related]
6. Cancer chemotherapy.
Sartorelli AC; Creasey WA
Annu Rev Pharmacol; 1969; 9():51-72. PubMed ID: 4892435
[No Abstract] [Full Text] [Related]
7. [L-asparaginase--first specific cytostatic].
Marquardt H
Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
[No Abstract] [Full Text] [Related]
8. Biological and phytochemical evaluation of plants. 8. Isolation of a new alkaloid from Sanguinaria canadensis.
Tin-Wa M; Farnsworth NR; Fong HH; Trojanek J
Lloydia; 1970 Jun; 33(2):267-9. PubMed ID: 5495516
[No Abstract] [Full Text] [Related]
9. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection.
Vlietinck AJ; De Bruyne T; Apers S; Pieters LA
Planta Med; 1998 Mar; 64(2):97-109. PubMed ID: 9525100
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experience in the treatment of malignant lymphomas with Vinca rosea alkaloids].
Prato V; Mazza U; Uslenghi E; Battistini V; Bianco G
Cancro; 1968; 21():Suppl 6:79-85. PubMed ID: 4906145
[No Abstract] [Full Text] [Related]
11. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
12. Tumor inhibitors. I. Preliminary investigation of antitumor activity of Sarracenia flava.
Miles DH; Kokpol U; Zalkow LH; Steindel SJ; Nabors JB
J Pharm Sci; 1974 Apr; 63(4):613-5. PubMed ID: 4828716
[No Abstract] [Full Text] [Related]
13. Tumor inhibitors. XXI. Active principles of Acer negundo and Cyclamen persicum.
Kupchan SM; Hemingway RJ; Knox JR; Barboutis SJ; Werner D; Barboutis MA
J Pharm Sci; 1967 May; 56(5):603-8. PubMed ID: 6032773
[No Abstract] [Full Text] [Related]
14. Antineoplastic principles in plants: recent developments in the field.
Hartwell JL; Abbott BJ
Adv Pharmacol (1962); 1969; 7():117-209. PubMed ID: 4906303
[No Abstract] [Full Text] [Related]
15. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
16. [Antineoplastic effect and toxicity of the alkaloid of Crotalaria assamica].
Zhonghua Yi Xue Za Zhi; 1973; 8():472-7. PubMed ID: 4200745
[No Abstract] [Full Text] [Related]
17. Recent advances in chemotherapy of lymphoma.
Lenhard RE; Owens AH
Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
[No Abstract] [Full Text] [Related]
18. The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo.
Marmont AM; Damasio EE
Blood; 1967 Jan; 29(1):1-21. PubMed ID: 5334796
[No Abstract] [Full Text] [Related]
19. Status and perspectives in chemotherapy of Hodgkin's disease.
Frei E
Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
[No Abstract] [Full Text] [Related]
20. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
Zarrilli D; Perrone V; Pergola M
Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
